• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Journal article

Fludarabine, cyclophosphamide, and rituximab chemotherapy followed by rituximab maintenance in follicular lymphoma: High efficacy may come at a cost?

CS Tam, JF Seymour

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2011

DOI: 10.3109/10428194.2011.575491

University of Melbourne Researchers

Constantine Tam's Profile Picture
Constantine Tam Author

John Seymour's Profile Picture
John Seymour Author

Citation metrics

3Scopus
3Web of Science
2Dimensions

Keywords

Plus Cyclophosphamide
Combination Chemotherapy
Chronic Lymphocytic-Leukemia
3211 Oncology and Carcinogenesis
Cancer
Trial
Indolent
Rare Diseases
Phase-3
Therapy
Orphan Drug
Mitoxantrone
Life Sciences & Biomedicine
6.1 Pharmaceuticals
Lymphoma
Hematology
Science & Technology
Lymphatic Research
3201 Cardiovascular Medicine and Haematology
32 Biomedical and Clinical Sciences
Oncology

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224